Css LLC Bristol Myers Squibb CO Transaction History

Css LLC

$999 Million
Q3 2024

A detailed history of Css LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Css LLC holds 26,630 shares of BMY stock, worth $1.54 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

26,630

Previous 30,300 12.11%

Holding current value

$1.54 Million

Previous $1.26 Million 9.54%

% of portfolio

0.14%

Previous 0.12%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $145,552 - $189,922	-3,670 Reduced 12.11%	26,630 $1.38 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $644,000 - $847,840	16,000 Added 111.89%	30,300 $1.26 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $23,990 - $27,200	-500 Reduced 3.38%	14,300 $775,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $242,399 - $289,250	-5,000 Reduced 25.25%	14,800 $759,000
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $40,523 - $45,311	700 Added 3.66%	19,800 $1.15 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $127,420 - $141,480	2,000 Added 11.7%	19,100 $1.22 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $98,564 - $111,795	1,500 Added 9.62%	17,100 $1.19 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $34,240 - $40,545	500 Added 3.31%	15,600 $1.12 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $520 - $307,360	4,000 Added 36.04%	15,100 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $145,240 - $159,960	2,000 Added 21.98%	11,100 $855,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $61,480 - $73,720	-1,000 Reduced 9.9%	9,100 $664,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $268,150 - $312,600	5,000 Added 98.04%	10,100 $630,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $260,022 - $283,164	-4,200 Reduced 45.16%	5,100 $341,000
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $344,172 - $387,091	-5,800 Reduced 38.41%	9,300 $587,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $173,220 - $196,290	3,000 Added 24.79%	15,100 $936,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $235,726 - $275,587	-4,300 Reduced 26.22%	12,100 $712,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $1.6 Million - $2.33 Million	-34,559 Reduced 67.82%	16,400 $913,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $2.51 Million - $3.27 Million	50,959 New	50,959 $3.27 Million

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Account